Transgenic models to study the actions of cytokines in the central nervous system.
To better understand the actions of cytokines in the mammalian central nervous system (CNS), we have developed transgenic mice in which the expression of various cytokines including interleukin (IL)-3, IL-6, IL-12, interferon-alpha or tumor necrosis factor-alpha was targeted to astrocytes under the transcriptional control of the glial fibrillary acidic protein (GFAP) promoter. Transgenic lines displaying low astrocyte expression of the respective cytokine were developed and characterized. The findings indicate that expression of these different cytokines in the intact CNS produces divergent inflammatory responses which are associated with the development of wide-ranging and progressive molecular, cellular and functional CNS impairments. These transgenic mice provide a powerful tool which we are now exploiting further to define novel mechanisms that might underlie the individual cytokine-driven neuroinflammatory responses. To date the results clearly show there are distinct model-associated patterns of cerebral expression of key molecules involved in the inflammatory response including the cellular adhesion molecules, chemokines, major histocompatibility complex molecules and the matrix metalloproteinases. In conclusion, these GFAP-cytokine transgenic mice highlight the potent and diverse array of actions mediated by cytokines when expressed in the CNS and provide a valuable resource to further our knowledge of the mechanisms by which cytokines exert their effects.
Campbell
I L
IL
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, Calif., USA. icamp@scripps.edu
Stalder
A K
AK
Akwa
Y
Y
Pagenstecher
A
A
Asensio
V C
VC
D000818:Animals; D002493:Central Nervous System Diseases / Q000276:immunology*; D016207:Cytokines / Q000235:genetics* / Q000276:immunology*; D004195:Disease Models, Animal; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic
D016207:Cytokines